Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study-Reference-Cited by-同舟云学术

Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study

Published:2021-06-20 Issue: Volume: Page:
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Blesl Andreas¹^ORCID,Binder Lukas¹,Högenauer Christoph¹²^ORCID,Wenzl Heimo¹,Borenich Andrea³,Pregartner Gudrun³,Berghold Andrea³,Mestel Sigrid¹,Kump Patrizia¹,Baumann‐Durchschein Franziska¹,Petritsch Wolfgang¹

Affiliation:

1. Department of Internal Medicine Division of Gastroenterology and Hepatology Medical University of Graz Graz Austria

2. Biotechmed Graz Austria

3. Institute for Medical Informatics, Statistics and Documentation Medical University of Graz Graz Austria

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16478

Reference46 articles.

1. Crohn's disease;Torres J;Lancet,2017

2. Ulcerative colitis;Ungaro R;Lancet,2017

3. Tumour‐necrosis‐factor antibody treatment in Crohn's disease;Derkx B;Lancet,1993

4. https://www.ema.europa.eu/en/medicines/human/EPAR/remicade.

5. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts P;N Engl J Med,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab;Advances in Therapy;2024-08-14

2. Challenges in IBD Research 2024: Precision Medicine;Inflammatory Bowel Diseases;2024-05-01

3. Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2024-04-23

4. Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study;Digestive and Liver Disease;2024-01

5. Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study;Journal of Gastrointestinal and Liver Diseases;2023-12-22